Investigation and analysis of anti diabetic drugs in our hospital during 2012 to 2016
10.3969/j.issn.1005-1678.2017.06.153
- VernacularTitle:2012~2016年本院抗糖尿病药物的调查研究分析
- Author:
Lubiao BU
;
Qianzhou LV
- Keywords:
DDDs;
antidiabetic drugs;
daily cost;
analysis of drug use
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):400-402
- CountryChina
- Language:Chinese
-
Abstract:
Objective To use in our hospital during 2012 to 2016 anti diabetic drugs were investigated in the analysis, and provide the basis for clinical treatment.MethodsThe drug collected in our hospital during 2012 to 2016 anti diabetic drug name, manufacturer, specifications, quantity, amount, amount, using Excel 2007 for data processing, calculation of DDDs (DDDs) and daily cost (DDC).ResultsFrom 2012 to 2016, the antidiabetic drugs in our hospital the total expenses increased from 12 million 311 thousand and 500 yuan to 19 million 467 thousand and 800 yuan, up 58.13% The amount of consumption.The top three anti diabetic drugs for insulin, sulfonylurea, biguanides;DDDs three for insulin, sulfonylureas, alpha glucosidase inhibitors;DDC three drugs was the highest in Epalrestat Tablets, Insulin Glargine Injection, Insulin Aspart 30 Injection.ConclusionThe treatment of diabetes in our hospital during 2012 to 2016 drug use is more reasonable, the insulin dosage, some new oral proportion is increasing.
